A new treatment for dust mite allergies has won approval from the U.S. Food and Drug Administration. Odactra is a year-round, once-a-day tablet that’s dissolved under the tongue. It’s approved for use ...

Adolescents aged 12 to 17 years with allergic rhinitis induced by house dust mites now can take a sublingual immunotherapy tablet approved by the FDA after review of multiple trials in this age group.

Odactra provides patients an alternative treatment to allergy shots. The Food and Drug Administration (FDA) has approved Odactra (Merck) sublingual tablets for the treatment of house dust mite ...

Dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Signs of dust mite allergy include those common to hay fever, such as sneezing and runny nose. Many people with ...

NEW YORK (Reuters Health) - Based on two dozen clinical trials, U.S. researchers find that expensive mattress covers make no difference in reducing dust mite allergies or their symptoms. Up to 40 ...

LOUISVILLE, Ky. — Allergen-specific immunotherapy showed efficacy among patients with atopic and contact dermatitis overlap syndrome, according to results of a pilot study. The results were presented ...

The global house dust mite allergy treatment market size was US$ 1.5 billion in 2021. The global house dust mite allergy treatment market size is forecast to reach US$ 4.6 billion by 2030, growing at ...

Definition By Mayo Clinic staff Dust mite allergy is an immune system reaction to a certain dust mite protein. This reaction triggers inflammation in the lining of the nasal passages (allergic ...

Monash University researchers are working on a vaccine that could completely cure asthma brought on by house dust mite allergies. If successful, the vaccine would have the potential to cure sufferers ...